7 results
8-K
EX-99.3
ELTX
Elicio Therapeutics, Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
of the product candidate, as well as manufacturing process development and product quality evaluation, continues after the IND is submitted.
An IND goes
424B3
ELTX
Elicio Therapeutics, Inc.
28 Apr 23
Prospectus supplement
4:07pm
, and product quality attractiveness would be high), comprising population growth, changes in the incidence of the diseases and that pricing would
S-4/A
vfb 1asnnptz0blst
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
- Prev
- 1
- Next